These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells. Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169 [TBL] [Abstract][Full Text] [Related]
3. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice. Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699 [TBL] [Abstract][Full Text] [Related]
4. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623 [TBL] [Abstract][Full Text] [Related]
5. Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation. Edinger M J Clin Invest; 2016 Apr; 126(4):1248-50. PubMed ID: 26999608 [TBL] [Abstract][Full Text] [Related]
6. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance. Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q Front Immunol; 2021; 12():686439. PubMed ID: 34616392 [TBL] [Abstract][Full Text] [Related]
8. Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients. Sicard A; Lamarche C; Speck M; Wong M; Rosado-Sánchez I; Blois M; Glaichenhaus N; Mojibian M; Levings MK Am J Transplant; 2020 Jun; 20(6):1562-1573. PubMed ID: 31957209 [TBL] [Abstract][Full Text] [Related]
9. Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor. Noyan F; Zimmermann K; Hardtke-Wolenski M; Knoefel A; Schulde E; Geffers R; Hust M; Huehn J; Galla M; Morgan M; Jokuszies A; Manns MP; Jaeckel E Am J Transplant; 2017 Apr; 17(4):917-930. PubMed ID: 27997080 [TBL] [Abstract][Full Text] [Related]
10. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation. Gille I; Claas FHJ; Haasnoot GW; Heemskerk MHM; Heidt S Front Immunol; 2022; 13():874157. PubMed ID: 35720402 [TBL] [Abstract][Full Text] [Related]
11. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy. Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125 [TBL] [Abstract][Full Text] [Related]
12. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection. Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842 [TBL] [Abstract][Full Text] [Related]
14. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance. Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z Front Immunol; 2018; 9():2359. PubMed ID: 30369931 [TBL] [Abstract][Full Text] [Related]
15. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes. Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558 [TBL] [Abstract][Full Text] [Related]
17. Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque. Ellis GI; Coker KE; Winn DW; Deng MZ; Shukla D; Bhoj V; Milone MC; Wang W; Liu C; Naji A; Duran-Struuck R; Riley JL Cell Rep Med; 2022 May; 3(5):100614. PubMed ID: 35551746 [TBL] [Abstract][Full Text] [Related]
18. Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells. Dawson NAJ; Rosado-Sánchez I; Novakovsky GE; Fung VCW; Huang Q; McIver E; Sun G; Gillies J; Speck M; Orban PC; Mojibian M; Levings MK Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32817364 [TBL] [Abstract][Full Text] [Related]
19. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets. Wu X; Chen PI; Whitener RL; MacDougall MS; Coykendall VMN; Yan H; Kim YB; Harper W; Pathak S; Iliopoulou BP; Hestor A; Saunders DC; Spears E; Sévigny J; Maahs DM; Basina M; Sharp SA; Gloyn AL; Powers AC; Kim SK; Jensen KP; Meyer EH Front Immunol; 2024; 15():1415102. PubMed ID: 39007132 [TBL] [Abstract][Full Text] [Related]
20. Building a CAR-Treg: Going from the basic to the luxury model. Rosado-Sánchez I; Levings MK Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]